Investment Management
* NOTE: This High Risk Equity Options Strategy Is Only For Investors Who Can Afford Short Term Price Risk & Volatility * JPMorgan Chase (NYSE:JPM) is scheduled to report 3Q 2014 earnings before the bell on Tuesday, October 14th. The results are typically released at 7:00 a.m. EST, with a conference call available at JPMorgan Chase […]
* NOTE: This High Risk Equity Call Option Strategy is Only For Investors who have the appetite for short term volatility and price risk * Samsung warns of a very soft quarter, with profits down 60% year-over-year * Pre-orders for the iPhone 6 in China are through 8 million and rising quickly * Apple’s Q1 2015 will likely […]
* On 6 Aug we advised to Buy Priceline Aug $1285 Calls before 2Q Earnings: http://www.bluephoenixfinancials.com/options-strategies/priceline-buy-aug-1285-calls-2q-earnings/ * On 8 Aug 2014, Price Aug $1285 Calls traded as low as $29.52 * On 11 Aug 2014, Priceline Aug 2014 Calls traded as high as $46.40 * Investors who followed our advice and bought at $40 and more […]
* NOTE: This is a High Risk Call Options Buy Strategy That Is Only Meant For Investors Who CAn Afford Short Term Price Risk & Volatility * The Priceline Group Inc. operates as an online travel company. The company’s products include Booking.com, which provides online hotel reservation services on a worldwide basis with approximately 425,000 […]
* On 23 July 2014, We Advised To Buy Gilead Sciences Aug 2014 $90 Call Options. Target: $4.50: http://www.bluephoenixfinancials.com/options-strategies/gilead-sciences-aug-2014-90-call-options-buy-2q-earnings/ * At the time of our advice Gilead Aug 2014 $90 were trading at $3.18 * On 24 July 2014, Gilead Sciences Aug 2014 $90 Call Options traded as high as $4.50, which was our target price […]
Sign up our newsletter for FREE financial advice and investment tips delivered to your inbox on weekly basis.
Want to keep in touch with news from Blue Phoenix Financials? Subscribe to our RSS feed using by clicking on the button to the right, or subscribe to our newsletter by filling out the form below.